Atlas Trials

Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery

Clinical trial NCT04087096 · COMPLETED

Trial details

NCT number
NCT04087096
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Bariatric Surgery CandidateBone Loss
Start date
2020-08-24
Primary completion
2024-08-06
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.